Pharmaceutical formulation for use in the treatment and/or prevention of restenosis
US10363227B2 · kind B2 · utility
0Cited by
3References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 2014 |
| Grant date | Jul 30, 2019 |
| Priority date | — |
| Expiry date | Mar 27, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/422
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to a pharmaceutical formulation for use in the treatment and/or prevention of restenosis in a subject in need thereof. Methods of treatment and/or prevention are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.